Alexander disease: Past and present

Cellular and Molecular Life Sciences

Volumn 61, Issue 21, 2004, Pages 2750-2752

  Hanefeld, F A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CRYSTALLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN 27; UBIQUITIN;

ALEXANDER DISEASE; ASTROCYTE; ASTROCYTOMA; DNA DETERMINATION; GENE MUTATION; GROWTH RETARDATION; HETEROZYGOSITY; HUMAN; HYDROCEPHALUS; INTRACRANIAL PRESSURE; LUNG EMBOLISM; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; MYELINATION; NEUROFIBROMATOSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; SEIZURE; SHORT SURVEY;

ADULT; ALEXANDER DISEASE; CHILD; HISTORY, 20TH CENTURY; HUMANS;

EID: 11144249812     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4291-9     Document Type: Short Survey

References (16)

1. Alexander W. S. (1949) Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72: 373-381
2. Crome L. (1953) Megalencephaly associated with hyaline panneuropathy. Brain 76: 215-228
3. Hallervorden J. (1961) Die Markscheidenentwicklung und die Rosenthalschen Fasern. [The development of the myelin sheath and Rosenthal's fibers] Dtsch. Z. Nervenheilkd. 181: 547-580
4. Friede R. L. (1964) Alexander's disease. Arch. Neurol. 11: 414-422
5. Van der Knaap M. S., Naidu S., Breiter S. N., Blaser S., Stroink H., Springer S., Begeer J. C. et al. (2001) Alexander disease: diagnosis with MR imaging. Am. J. Neuroradiol. 22: 541-552
6. Brockmann K., Dechent P., Meins M., Haupt M., Sperner J., Stephani U. et al. (2003) Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J. Neurol. 250: 300-306
7. Johnson A. B. (2002) Alexander disease: a review and the gene. Int. J. Dev. Neurosci. 20: 391-394
8. Messing A., Head M. W., Galles K., Galbreath E. J., Goldman J. E. and Brenner M. (1998) Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am. J. Pathol. 152: 391-398
9. Messing A. and Brenner M. (2003) GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 43: 87-90
10. Brenner M., Johnson A. B., Boespflug-Tanguy O., Rodriguez D., Goldman J. E. and Messing A. (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27: 117-120
11. Rodriquez D., Gauthier F., Bertini E., Bugiani M., Brenner M., N'guyen S. et al. (2001) Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am. J. Hum. Genet. 69: 1134-1140
12. Gorospe J. R., Naidu S., Johnson A. B., Puri V., Raymond G. V., Jenkins S. D. et al. (2002) Molecular findings in symptomatic and pre-symtpomatic Alexander disease patients. Neurology 58: 1494-1500
13. Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D. and Rodriguez D. (2004) Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell. Mol. Life Sci. 61: 369-385
14. Quinlan R. (2001) Cytoskeletal catastrophe causes brain degeneration. Nat. Genet. 27: 10-11
15. Li R., Messing A., Goldman J. E. and Brenner M. (2002) GFAP mutations in Alexander disease. Int. J. Dev. Neurosci. 20: 259-268
16. Bomont P., Cavalier L., Blondeau F., Ben Hamida C., Belal S., Tazir M. et al. (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet. 26: 370-374